Immunic to announce financial results for the third quarter ended september 30, 2023, and provide corporate update

– webcast to be held at 8:00 am et on november 14, 2023 – new york , nov. 7, 2023 /prnewswire/ -- immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the third quarter ended september 30, 2023, including a corporate update, on tuesday, november 14, 2023, before the opening of the u.s. financial markets. a webcast will follow at 8:00 am et.
IMUX Ratings Summary
IMUX Quant Ranking